Answers to Questions at previous Investormeetcompany event8 Jan 2026 23:30
As we wait in anticipation for the forthcoming TU, I highly recommend reading the answers given to investor questions at the last investor meet company event in September 2025. In particular the answers given to Q4 and Q21. Clearly their scale inhibitors are going to be the key to future riches!
Q4 answer: “I think I addressed some of this, the presentation, as our scale inhibitor advances to being a standard ingredient, and as we're working our way through the private label formulators and the purpose-driven brands, we are getting interest with the large global players, and when we get there, those are very large volumes. When we get to those volumes where we play, you know, we, will need another plant, and where we put it, depends on exactly which player comes through when. But, when we do get there, it'll be the types of volumes, that'll, we believe, will be very easy, for us to get financing, for a larger plant on it.”
Q21 answer: “We very much want to, we very much have a, significant calling effort on the global leaders. They, know about us, they know about how our chemistries work, they can see that our chemistries are working in the marketplace. We have, we have projects, progressing, significant sized projects with them. It just takes them out of, it takes time. The, the reason to focus. On these smaller brands is to get to a profitable stage and to get, your, ingredients ubiquitously out on, onto as many product labels as possible so that, you know, there's high certainty that your product's going to work, that you've been delivering and fulfilling customer needs for multiple years, and that your product works on it. We are absolutely going after, we're absolutely going after the larger players, and I think, over time, we will be successful. Our scale inhibitors are that good.”